Improving the solubility, activity, and stability of reteplase using in silico design of new variants
Reteplase (recombinant plasminogen activator, r-PA) is a thrombolytic agent recombined from tissue-type plasminogen activator (t-PA), which has several prominent features such as strong thrombolytic ability and E. coli expressibility. Despite these outstanding features, it demonstrates reduced fibri...
Saved in:
Main Authors: | Hooria Seyedhosseini Ghaheh (Author), Mohamad Reza Ganjalikhany (Author), Parichehreh Yaghmaei (Author), Morteza Pourfarzam (Author), Hamid Mir Mohammad Sadeghi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies
by: Iman Esmaili, et al.
Published: (2018) -
Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment
by: Maryam Beheshti Isfahani, et al.
Published: (2023) -
Rational design of a new mutant of tobacco etch virus protease in order to increase the in vitro solubility
by: Hossein Mohammadian, et al.
Published: (2020) -
Successful treatment of massive pulmonary embolism with reteplase
by: Ali Çoner, et al.
Published: (2018) -
Health Technology Assessment of TNK-ase vs. Reteplase in the Treatment of Acute Myocardial Infarction in Iran
by: salman bashzar, et al.
Published: (2018)